Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Model suggests there are fewer people with HIV in the US than thought, and more of them on therapy

A study comparing recorded diagnoses of HIV with subsequent records of viral load and CD4 tests suggests that the number of people with HIV in the

Published
20 April 2016
By
Gus Cairns
Black Lives Matter: What's PrEP got to do with it?

There have been major developments in both treatment and prevention of HIV/AIDS in the U.S. in recent years and one of the most promising ones is Pre-Exposure Prophylaxis or PrEP. However, as the persistently unacceptable high rates of new HIV infections underscore, PrEP and other biomedical interventions tools are not being applied effectively in Black communities. While new HIV diagnoses in the U.S. as a whole fell 19 percent between 2005 and 2014, new cases among Black gay and bisexual men, for example, increased by 87 percent.

Published
19 April 2016
From
PR Newswire
NHS To Reconsider Its Decision Not To Provide The HIV Prevention Drug

The NHS in England is to reconsider its controversial decision not to provide the drug that prevents HIV. Faced with the threat of legal action by one of Britain’s leading HIV charities, NHS England’s lawyers have said a dedicated committee will meet next month to look again at the pronouncement.

Published
19 April 2016
From
BuzzFeed News
The NHS will now consider putting PrEP back into the NHS decision-making process following the threat of legal action from the National AIDS Trust (NAT)

On 21 March, NHS England announced it was pulling the plug on its decision-making process on whether to make HIV pre-exposure prophylaqxis available. the HIV charity received a response from NHS England stating that ‘NHS England will carefully consider its position on commissioning PrEP in light of [NAT’s] representations’. NHS England will now meet in May to decide whether to put PrEP back into the decision-making process from which it had previously been removed.

Published
19 April 2016
From
National AIDS Trust
Mr Gay World Entry Gets Personal on PrEP and Testing Poz

Sadiq Ali is a contestant for Mr Gay World; he is fighting both HIV stigma and for the adoption of PrEP in the United Kingdom.

Published
18 April 2016
From
My Fabulous Disease
UNAIDS urges countries to adopt a people-, rights- and health-centred approach to reverse the HIV epidemic among people who inject drugs

A new UNAIDS report says insufficient coverage of harm reduction programmes and policies that criminalize and marginalize people who inject drugs are failing to reduce new HIV infections.

Published
18 April 2016
From
UNAIDS
Gilead Statement on the Approval of PrEP in Peru

Gilead Sciences, Inc. is pleased to share that the Peru Ministry of Health has approved the use of once- daily oral Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) as pre-exposure prophylaxis (PrEP), in combination with safer sex practices, to help reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk .

Published
14 April 2016
From
Gilead Sciences
Chemsex: why is gay sex causing straight panic?

Since last year’s release of Chemsex, described by the Guardian as a “scary but valuable documentary”, the drug-fuelled sexual practices of some gay men have increasingly become a matter of heated debate, both within the gay community and in the national press. But “chemsex” is not receiving the depth of critical analysis it badly needs.

Published
14 April 2016
From
The Conversation
'Female' Condoms Cost Too Much: A Call for HIV Prevention Equality for Receptive Sex Partners

What if female condoms cost the same as male condoms? The FC2 (the only female condom brand currently available in the U.S.) typically costs between $2 to $3.50 each, three to four times that of a typical male condom selling commercially for less than $1.

Published
13 April 2016
From
The Body
People who use drugs still adherent to PrEP

New research conducted with a group of PrEP clients at the San Francisco AIDS Foundation PrEP clinic suggests that people who use substances adhere to PrEP and stay in care at about the same rate as people who do not use drugs.

Published
13 April 2016
From
BETA blog

Filter by country